Position in IMRX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$49,900
New position
Shares Held
10,000
first reported quarter
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#91
of 111 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026VestGen Advisors, LLC holds $4,407,229 across 7 Biotechnology names. IMRX ranks #6 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
36,912 | $1,306,315 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,199 | $1,092,309 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
13,126 | $1,069,900 | |
| 4 | EXEL |
Exelixis, Inc.
|
13,451 | $731,868 | |
| 5 | ABCL |
AbCellera Biologics Inc.
|
19,652 | $154,268 | |
| 6 | IMRX |
Immuneering Corp
This page
|
10,000 | $49,900 | |
| 7 | GOSS |
Gossamer Bio, Inc.
|
16,177 | $2,669 |
All Filings in IMRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49,900 | 10,000 | Shares | Sole | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||